0
DEAR DR. ROACH: A person who works in the medical field told me that she is against vaccinations. The reason she gave is that when you put a specific vaccine
0
The former PM says only a vaccine or drugs - unavailable at the time - could have averted the curbs.
0
The former PM says only a vaccine or drugs - unavailable at the time - could have averted the curbs.
0
Discovery means potential protective treatments could be developed to block thrombosis from developing following vaccination.
0
The state of Tennessee has agreed to pay $150,000 to settle a federal lawsuit by its former vaccine leader over her firing during the COVID-19 pandemic
0
The 54-year-old’s cause of death remains unclear, with an initial post-mortem coming back as ‘inconclusive’
0
More than 38 million COVID-19 vaccine doses have been administered in Ontario as of Oct. 8, with 23,002 reports of adverse reactions, an incidence of 0.06 per cent, Public Health Ontario says
0
The vaccine is designed to help produce anti-cocaine antibodies in the body of a person who is chemically dependent on the substance.
0
Malaria has re-emerged in my home state of Florida, and will spread further thanks to climate change, says Devi Sridhar, chair of global public health at the University of Edinburgh
0
The World Health Organization has recommended a shot called R21 to prevent the disease in children.
0
Exclusive: Social media users report receiving ‘priority’ vaccine letters for relatives who died years ago
0
A study of 500 health people has found that antibodies can develop against polyethylene glycol (PEG), a substance used in cosmetics, food and medicine, which might hinder the effectiveness of drugs.
0
Malaria parasites from patients who fail atovaquone therapies are highly drug-resistant, with mutations at Y268 in cytochrome b. Here the authors show that this mutation results in multiple defects in the parasite’s development and prevents transmi ...
0
<p>Johns Hopkins researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown in a new study that resistance may not be the challenge scientists thought it was, particularly when using atovaquo ...
0
Background and Objectives: Existing data regarding occurrence of Guillain-Barré syndrome (GBS) following COVID-19 infection and vaccination are inconclusive. We aimed to assess the association between GBS and both SARS-CoV-2 infection and COVID-19 v ...
0
Paxlovid will transition to the private market in November as demand for Covid vaccines and treatments slumps nationwide.